Skip to main navigation
60 Degrees Pharma
Investor Relations
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Leadership
    • Committee Composition
  • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Email Alerts
    • RSS Feeds
    • Contact IR

SEC Filing Details

btn >> Banner Menu

Sign up for Email Alerts Investor Presentation

Document Details

Form
8-K
Filing Date
Sep 14, 2026
Document Date
Sep 12, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
60 Degrees Pharmaceuticals, Inc.
Issuer
60 DEGREES PHARMACEUTICALS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

202-327-5422
1025 Connecticut Ave. NW, Suite 1000,
Washington, DC 20036

  • Site Map |
  • Terms of Use |
  • Privacy Policy

Copyright © 2026 60 Degrees Pharmaceuticals, Inc. All Rights Reserved.

  • Our Company
  • Vector-Borne Diseases
  • Products
  • Clinical Pipeline
  • News
  • Investors
  • Contact Us
Search Investors